• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种转甲状腺素蛋白变体的X射线晶体学研究:对淀粉样变发生机制的进一步见解

X-ray crystallographic studies of two transthyretin variants: further insights into amyloidogenesis.

作者信息

Neto-Silva Ricardo M, Macedo-Ribeiro Sandra, Pereira Pedro J B, Coll M, Saraiva Maria J, Damas Ana M

机构信息

Molecular Structure Group, Institute for Molecular and Cell Biology, Rua do Campo Alegre No. 823, 4150 Porto, Portugal.

出版信息

Acta Crystallogr D Biol Crystallogr. 2005 Mar;61(Pt 3):333-9. doi: 10.1107/S0907444904034316. Epub 2005 Feb 24.

DOI:10.1107/S0907444904034316
PMID:15735344
Abstract

Transthyretin (TTR) is a homotetrameric plasma protein that, as a result of a set of not yet fully characterized conformational changes, forms fibrillar aggregates that are the major protein component of amyloid deposits. More than 80 mutations associated with TTR amyloid deposition have been described in the literature. X-ray crystallography was used to elucidate the three-dimensional structure of two important TTR variants: TTR Y78F, an amyloidogenic protein, and TTR R104H, which is associated with a protective effect over the amyloidogenic V30M mutation. The structures of those two TTR variants have been determined in space group P2(1)2(1)2 to 1.55 and 1.60 angstroms resolution, respectively, using molecular-replacement techniques. Detailed analysis of the protein model for TTR Y78F indicates a destabilization of the contacts between the alpha-helix and AB loop and the body of the molecule, intimately related to the amyloidogenic nature; contrastingly, in the TTR R104H variant new contacts involving the N-terminal region and His104 are clearly antagonists of amyloid formation.

摘要

转甲状腺素蛋白(TTR)是一种同四聚体血浆蛋白,由于一系列尚未完全明确的构象变化,会形成纤维状聚集体,而这些聚集体是淀粉样沉积物的主要蛋白质成分。文献中已描述了80多种与TTR淀粉样沉积相关的突变。X射线晶体学被用于阐明两种重要的TTR变体的三维结构:TTR Y78F,一种淀粉样蛋白生成蛋白,以及TTR R104H,它对淀粉样蛋白生成性V30M突变具有保护作用。使用分子置换技术,分别在空间群P2(1)2(1)2中以1.55埃和1.60埃的分辨率确定了这两种TTR变体的结构。对TTR Y78F蛋白质模型的详细分析表明,α-螺旋与AB环以及分子主体之间的接触不稳定,这与淀粉样蛋白生成的性质密切相关;相反,在TTR R104H变体中,涉及N端区域和His104的新接触显然是淀粉样蛋白形成的拮抗剂。

相似文献

1
X-ray crystallographic studies of two transthyretin variants: further insights into amyloidogenesis.两种转甲状腺素蛋白变体的X射线晶体学研究:对淀粉样变发生机制的进一步见解
Acta Crystallogr D Biol Crystallogr. 2005 Mar;61(Pt 3):333-9. doi: 10.1107/S0907444904034316. Epub 2005 Feb 24.
2
The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.2,4-二硝基苯酚与野生型和淀粉样变甲状腺素转运蛋白的结合。
Acta Crystallogr D Biol Crystallogr. 2006 May;62(Pt 5):512-9. doi: 10.1107/S0907444906006962. Epub 2006 Apr 19.
3
Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.酸性pH诱导淀粉样变突变型转甲状腺素蛋白的构象变化。
J Mol Biol. 2007 Feb 23;366(3):711-9. doi: 10.1016/j.jmb.2006.11.076. Epub 2006 Dec 1.
4
Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.转甲状腺素蛋白稳定性作为淀粉样变发生的关键因素:原子分辨率的X射线分析
J Mol Biol. 2001 Mar 2;306(4):733-44. doi: 10.1006/jmbi.2000.4415.
5
The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.甲状腺素运载蛋白的酸介导变性途径产生一种可自组装成淀粉样蛋白的构象中间体。
Biochemistry. 1996 May 21;35(20):6470-82. doi: 10.1021/bi952501g.
6
A comparative analysis of 23 structures of the amyloidogenic protein transthyretin.淀粉样蛋白转甲状腺素蛋白23种结构的比较分析。
J Mol Biol. 2000 Sep 22;302(3):649-69. doi: 10.1006/jmbi.2000.4078.
7
Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.对天然人甲状腺素运载蛋白四聚体内pH诱导的构象变化的结构洞察。
J Mol Biol. 2008 Oct 24;382(5):1157-67. doi: 10.1016/j.jmb.2008.07.029. Epub 2008 Jul 16.
8
Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis.通过蛋白质工程实现天然态的动力学稳定:对甲状腺素运载蛋白淀粉样变抑制作用的影响
J Mol Biol. 2005 Apr 8;347(4):841-54. doi: 10.1016/j.jmb.2005.01.050.
9
Intrinsic versus mutation dependent instability/flexibility: a comparative analysis of the structure and dynamics of wild-type transthyretin and its pathogenic variants.内在稳定性与突变依赖性不稳定性/灵活性:野生型转甲状腺素蛋白及其致病性变体的结构与动力学比较分析
J Struct Biol. 2004 Nov;148(2):153-68. doi: 10.1016/j.jsb.2004.06.007.
10
Different disease-causing mutations in transthyretin trigger the same conformational conversion.转甲状腺素蛋白中不同的致病突变引发相同的构象转换。
Protein Eng Des Sel. 2008 Mar;21(3):187-95. doi: 10.1093/protein/gzm086. Epub 2008 Feb 13.

引用本文的文献

1
Inhibitors of Transthyretin Amyloidosis: How to Rank Drug Candidates Using X-ray Crystallography Data.转甲状腺素蛋白淀粉样变性抑制剂:如何利用 X 射线晶体学数据对候选药物进行排序。
Molecules. 2024 Feb 18;29(4):895. doi: 10.3390/molecules29040895.
2
Thermodynamic Stability and Aggregation Kinetics of EF Helix and EF Loop Variants of Transthyretin.转甲状腺素蛋白 EF 螺旋和 EF 环变体的热力学稳定性和聚集动力学。
Biochemistry. 2021 Mar 16;60(10):756-764. doi: 10.1021/acs.biochem.1c00073. Epub 2021 Mar 1.
3
Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.
热焓驱动的转甲状腺素蛋白稳定化由 AG10 模拟物实现,该模拟物类似于一种天然存在的遗传变异体,可保护其免受转甲状腺素蛋白淀粉样变性。
J Med Chem. 2018 Sep 13;61(17):7862-7876. doi: 10.1021/acs.jmedchem.8b00817. Epub 2018 Aug 22.
4
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses.基于结构的动力学稳定剂设计可改善转甲状腺素淀粉样变性。
Curr Opin Struct Biol. 2010 Feb;20(1):54-62. doi: 10.1016/j.sbi.2009.12.009. Epub 2010 Feb 3.
5
Amyloidogenic potential of transthyretin variants: insights from structural and computational analyses.转甲状腺素蛋白变体的淀粉样变性潜能:来自结构和计算分析的见解
J Biol Chem. 2009 Sep 18;284(38):25832-41. doi: 10.1074/jbc.M109.017657. Epub 2009 Jul 14.